Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 201

1.

Interdependence of radial scar and proliferative disease with respect to invasive breast carcinoma risk in patients with benign breast biopsies.

Sanders ME, Page DL, Simpson JF, Schuyler PA, Dale Plummer W, Dupont WD.

Cancer. 2006 Apr 1;106(7):1453-61.

2.

Breast cancer risk in women with radial scars in benign breast biopsies.

Berg JC, Visscher DW, Vierkant RA, Pankratz VS, Maloney SD, Lewis JT, Frost MH, Ghosh K, Degnim AC, Brandt KR, Vachon CM, Reynolds CA, Hartmann LC.

Breast Cancer Res Treat. 2008 Mar;108(2):167-74. doi: 10.1007/s10549-007-9605-9. Epub 2007 May 22.

PMID:
18297395
3.

Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease.

Page DL, Kidd TE Jr, Dupont WD, Simpson JF, Rogers LW.

Hum Pathol. 1991 Dec;22(12):1232-9.

PMID:
1748429
4.

Radial scars in benign breast-biopsy specimens and the risk of breast cancer.

Jacobs TW, Byrne C, Colditz G, Connolly JL, Schnitt SJ.

N Engl J Med. 1999 Feb 11;340(6):430-6.

5.

Breast cancer risk associated with proliferative breast disease and atypical hyperplasia.

Dupont WD, Parl FF, Hartmann WH, Brinton LA, Winfield AC, Worrell JA, Schuyler PA, Plummer WD.

Cancer. 1993 Feb 15;71(4):1258-65. Review.

6.

Estrogen replacement therapy in women with a history of proliferative breast disease.

Dupont WD, Page DL, Parl FF, Plummer WD Jr, Schuyler PA, Kasami M, Jensen RA.

Cancer. 1999 Mar 15;85(6):1277-83.

PMID:
10189132
7.

A prospective study of the development of breast cancer in 16,692 women with benign breast disease.

Carter CL, Corle DK, Micozzi MS, Schatzkin A, Taylor PR.

Am J Epidemiol. 1988 Sep;128(3):467-77.

PMID:
3414655
8.

The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health Study.

Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ.

Cancer. 2006 Sep 15;107(6):1240-7.

9.

Lower-category benign breast disease and the risk of invasive breast cancer.

Wang J, Costantino JP, Tan-Chiu E, Wickerham DL, Paik S, Wolmark N.

J Natl Cancer Inst. 2004 Apr 21;96(8):616-20.

PMID:
15100339
10.

Prognostic significance of benign proliferative breast disease.

Bodian CA, Perzin KH, Lattes R, Hoffmann P, Abernathy TG.

Cancer. 1993 Jun 15;71(12):3896-907.

11.

Invasive breast cancer risk in women with sclerosing adenosis.

Jensen RA, Page DL, Dupont WD, Rogers LW.

Cancer. 1989 Nov 15;64(10):1977-83.

12.
13.

Benign breast disease and the risk of breast cancer.

Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, Suman VJ, Johnson J, Blake C, Tlsty T, Vachon CM, Melton LJ 3rd, Visscher DW.

N Engl J Med. 2005 Jul 21;353(3):229-37.

14.

Biopsy confirmed benign breast disease, postmenopausal use of exogenous female hormones, and breast carcinoma risk.

Byrne C, Connolly JL, Colditz GA, Schnitt SJ.

Cancer. 2000 Nov 15;89(10):2046-52.

PMID:
11066044
15.

Benign breast disease as a breast cancer risk in Japanese women.

Nomura Y, Tashiro H, Katsuda Y.

Jpn J Cancer Res. 1993 Sep;84(9):938-44.

PMID:
8407559
16.

Radial scar, complex sclerosing lesion and risk of breast cancer. Analysis of 175 cases in Northern Ireland.

Patterson JA, Scott M, Anderson N, Kirk SJ.

Eur J Surg Oncol. 2004 Dec;30(10):1065-8.

PMID:
15522552
17.

Multiplicity of benign breast lesions is a risk factor for progression to breast cancer.

Worsham MJ, Raju U, Lu M, Kapke A, Cheng J, Wolman SR.

Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5474-9.

18.

Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma.

Page DL, Salhany KE, Jensen RA, Dupont WD.

Cancer. 1996 Jul 15;78(2):258-66.

19.

Nonsteroidal antiinflammatory drugs, cyclooxygenase polymorphisms, and the risk of developing breast carcinoma among women with benign breast disease.

Gallicchio L, McSorley MA, Newschaffer CJ, Thuita LW, Huang HY, Hoffman SC, Helzlsouer KJ.

Cancer. 2006 Apr 1;106(7):1443-52.

20.

Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study.

Collins LC, Tamimi RM, Baer HJ, Connolly JL, Colditz GA, Schnitt SJ.

Cancer. 2005 May 1;103(9):1778-84.

Supplemental Content

Support Center